Trial record 1 of 1852 for:
parkinson's disease[ALL-FIELDS]
Nocturnal Parkinson's Disease Symptoms Study Group
This study has been completed.
Sponsor:
Chulalongkorn University
Information provided by (Responsible Party):
Roongroj Bhidayasiri, Chulalongkorn University
ClinicalTrials.gov Identifier:
NCT01662427
First received: August 7, 2012
Last updated: August 18, 2013
Last verified: August 2013
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
To study associate factor of Noctural Parkinson's Disease Symptoms and quality of life in Parkinson's disease patients and caregivers.
| Condition | Intervention |
|---|---|
|
Parkinson's Disease |
Other: Questionaire to assess Noctural Parkinson's Disease Symptoms |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | Nocturnal Parkinson's Disease Symptoms Study Group |
Resource links provided by NLM:
Further study details as provided by Chulalongkorn University:
Primary Outcome Measures:
- To assess Noctural Parkinson's Disease Symptoms [ Designated as safety issue: No ]
Secondary Outcome Measures:
- To assess quality of life in Parkinson's Disease patient [ Designated as safety issue: No ]
- To assess quality of life in caregiver of Parkinson's Disease patient [ Designated as safety issue: No ]
| Enrollment: | 300 |
| Study Start Date: | November 2012 |
| Study Completion Date: | August 2013 |
| Primary Completion Date: | August 2013 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Questionniare |
Other: Questionaire to assess Noctural Parkinson's Disease Symptoms
Questionaire to assess Noctural Parkinson's Disease Symptoms and quality of life
|
Eligibility| Ages Eligible for Study: | 30 Years to 90 Years (Adult, Senior) |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
Parkinson's disease patient and care givers
Criteria
Inclusion Criteria:
Idiopathic Parkinson's disease patient
Exclusion Criteria:
- Patient with Secondary Parkinsonism eg.Drug-induced Parkinsonism, Vascular Parkinsonism, exposure to toxin, Encephalitis
- Patient with Atypical Parkinsonial Syndromes eg. Parkinson-plus syndrome, Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
- Patient with Heredodegenerative parkinsonism eg. Spinocerebellar ataxias, Wilson's disease, Juvenile Huntington's disease
Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01662427
Please refer to this study by its ClinicalTrials.gov identifier: NCT01662427
Locations
| Thailand | |
| Roongroj Bhidayasiri | |
| Pathumwan, Bangkok, Thailand, 10330 | |
Sponsors and Collaborators
Chulalongkorn University
More Information
| Responsible Party: | Roongroj Bhidayasiri, Associate Professor, Chulalongkorn University |
| ClinicalTrials.gov Identifier: | NCT01662427 History of Changes |
| Other Study ID Numbers: | 6222012 |
| Study First Received: | August 7, 2012 |
| Last Updated: | August 18, 2013 |
| Health Authority: | Thailand: Ethical Committee |
Keywords provided by Chulalongkorn University:
|
Quality of life Noctural Parkinson's Disease Symptoms |
Additional relevant MeSH terms:
|
Parkinson Disease Parkinsonian Disorders Basal Ganglia Diseases Brain Diseases |
Central Nervous System Diseases Nervous System Diseases Movement Disorders Neurodegenerative Diseases |
ClinicalTrials.gov processed this record on September 26, 2016